Finance

Lists
Q3 2026 earnings • released • EPS beat +1.45% • Revenue beat +6.15%
See results
OM:NASDAQ
Outset Medical Inc
$4.23
+3.17%
(+0.13) 1D
Nov 6, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OM...
Open
$4.04
High
$4.24
Low
$4.04
Mkt. cap
79.51M
Avg. vol.
159.18K
Volume
38.60K
52-wk high
$12.47
52-wk low
$2.84
EPS
-$4.08
Beta
1.93
Shares outstanding
18.87M
No. of employees
310
Open
$4.04
High
$4.24
Low
$4.04
Mkt. cap
79.51M
Avg. vol.
159.18K
Volume
38.60K
52-wk high
$12.47
52-wk low
$2.84
EPS
-$4.08
Beta
1.93
Shares outstanding
18.87M
No. of employees
310
News stories
From web sources and news partners
About Outset Medical Inc
CEO-
Employees310
Founded2003
HeadquartersSan Jose, California, United States
SectorHealth Care
IndustryMedical device
Websiteoutsetmedical.com
Analyst ratings
Based on 3 analysts giving stock ratings to OM in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for OM in the last 3 months.
Highest
Current $4.23
$10.00 (+136.41%)
Average
$7.67 (+81.32%)
Lowest
$6.00 (+41.84%)
Analyst
Recommendation
Action
Price target
Projected
Date
Rick Wise
Stifel Nicolaus
Buy
Maintained
$6.00
+41.8%
11/05/2026
Josh Jennings
TD Cowen
Buy
Maintained
$10.00
+136.4%
11/05/2026
Kendall Au
RBC Capital
Hold
Maintained
$7.00
+65.5%
11/04/2026
Shagun Singh Chadha
RBC Capital
Hold
Maintained
$7.00
+65.5%
08/06/2026
William Katz
TD Cowen
Buy
Reiterated
$12.00
+183.7%
04/07/2026
Marie Thibault
BTIG
Buy
Maintained
$15.00
+254.6%
02/18/2026
Last report
Nov 4, 2026
Fiscal period
Q3 2026
-$0.68 / -$0.69
+1.45%beat
Revenue / Est. (USD)
33.60M / 31.65M
+6.15%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
29.43M
28.87M
27.86M
31.64M
Cost of goods sold
17.84M
16.64M
15.77M
18.35M
Cost of revenue
17.84M
16.64M
15.77M
18.35M
Research and development expenses
5.38M
5.06M
5.62M
5.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.03M
24.80M
23.40M
23.51M
Operating expense
27.40M
29.86M
29.01M
28.96M
Total operating expenses
45.24M
46.50M
44.78M
47.31M
Operating income
-15.81M
-17.63M
-16.92M
-15.68M
Other non operating income
-
-
-
-
EBT including unusual items
-17.43M
-19.40M
-18.76M
-17.76M
EBT excluding unusual items
-17.43M
-19.40M
-18.76M
-17.76M
Income tax expense
404.00K
95.00K
217.00K
220.00K
Effective tax rate
-2.32%
-0.49%
-1.16%
-1.24%
Other operating expenses
-
-
-
-
Net income
-17.84M
-19.49M
-18.98M
-17.98M
Net profit margin
-60.61%
-67.50%
-68.11%
-56.85%
Earnings per share
-0.69
-0.84
-0.83
-0.80
Interest and investment income
1.86M
1.67M
1.53M
1.35M
Interest expense
-3.48M
-3.44M
-3.37M
-3.44M
Net interest expenses
-1.62M
-1.77M
-1.84M
-2.09M
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.80M
-16.75M
-16.12M
-15.05M
Gain or loss from assets sale
3.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps